Apixaban
Ka morao
Apixaban ke inhibitor e khethang haholo ebile e fetoleloa morao ea Factor Xa e nang le boleng ba Ki ea 0.08 nM le 0.17 nM ho motho le mmutla, ka ho latellana[1].
Factor X, eo hape e tsejoang ka eponym Stuart-Prower factor, ke enzyme ea coagulation cascade.Factor X e sebelisoa, ka hydrolysis, ho factor Xa ka bobeli factor IX.Factor Xa is the activated form of the coagulation factorthrombokinase.Inhibiting Factor Xa e ka fana ka mokhoa o mong oa anticoagulation.Li-inhibitors tsa Direct Xa ke li-anticoagulants tse tsebahalang [2].
In vitro: Apixabanhas e bontšitse tekanyo e phahameng ea potency, selectivity, le katleho ho Factor Xa le Ki ea 0.08 nM le 0.17 nM bakeng sa Human Factor Xa le Rabbit Factor Xa, ka ho latellana [1].Apixaban e lelefatsa nako ea ho koala ha plasma e tloaelehileng ea motho ka li-concents (EC2x) tsa 3.6, 0.37, 7.4 le 0.4 μM, tse hlokehang ka ho latellana ho habeli nako ea prothrombin (PT), nako e fetotsoeng ea prothrombin (mPT), e entsoeng ka nako e itseng ea thromboplastin ( APTT) le HepTest.Ntle ho moo, Apixaban e bontšitse matla a phahameng ka ho fetisisa ho plasma ea batho le ea mmutla, empa matla a fokolang a plasma ea likhoto le lintja litlhahlobong tsa PT le APTT [3].
In vivo: Apixaban e hlahisitse pharmacokinetics e ntle ka ho fetisisa e nang le tumello e tlaase haholo (Cl: 0.02 L kg-1h-1), le palo e tlaase ea kabo (Vdss: 0.2 L / kg) ho ntja.Ntle ho moo, Apixaban e boetse e bonts'a halofo ea bophelo bo itekanetseng le T1 / 2 ea lihora tsa 5.8 le bioavailability e ntle ea molomo (F: 58%) [1].Ka har'a arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT) le mefuta ea meutlanyana ea carotid arterial thrombosis (ECAT), Apixaban e hlahisitse litlamorao tsa antithrombotic ka EC50 ea 270 nM, 110 nM le 70 nM ka mokhoa o itšetlehileng ka lethal dose [3. ].Apixaban e thibelitse haholo ts'ebetso ea Xa ka IC50 ea 0.22 μM ho mmutla ex vivo[4].Ka lichimpanzi, Apixaban o ile a boela a bontša palo e nyenyane ea ho aba (Vdss: 0.17 L kg-1), tumello e tlaase ea tsamaiso (Cl: 0.018 L kg-1h-1), le bioavailability e ntle ea molomo (F: 59%) [5].
Litšupiso:
Pinto DJP, Orwat MJ, Koch S, et al.Ho sibolloa ha 1-(4-methoxyphenyl) -7-oxo-6-(4-(2-oxopiperidin-1-yl) phenyl) -4, 5, 6, 7-tetrahydro-1 H-pyrazolo [3, 4- c] pyridine-3-carboxamide (Apixaban, BMS-562247), e matla haholo, e khethang, e sebetsang hantle, le ea molomo ea bioavailable inhibitor ea mali a coagulation factor Xa[J].Journal of chemistry ea meriana, 2007, 50 (22): 5339-5356.
Sidhu P S. Direct Factor Xa Inhibitors e le Anticoagulants[J].
Wong PC, Crain EJ, Xin B, et al.Apixaban, oral, e tobileng le e khethehileng haholo ea Xa inhibitor: in vitro, antithrombotic le antihemostaticstudies[J].Journal of Thrombosis le Haemostasis, 2008, 6 (5): 820-829.
Zhang D, He K, Raghavan N, et al.Metabolism, pharmacokinetics le pharmacodynamics ea factor Xa inhibitor apixaban ka mebutlanyana[J].Journal of thrombosis le thrombolysis, 2010, 29 (1): 70-80.
He K, Luettgen JM, Zhang D, et al.Preclinical pharmacokinetics le pharmacodynamics ea apixaban, e matla le e khethang factor Xa inhibitor[J].Koranta ea Europe ea metabolism ea lithethefatsi le pharmacokinetics, 2011, 36 (3): 129-139.
Apixaban ke inhibitor e khethang haholo ebile e fetoleloa morao ea Factor Xa e nang le boleng ba Ki ea 0.08 nM le 0.17 nM ho motho le mmutla, ka ho latellana[1].
Factor X, eo hape e tsejoang ka eponym Stuart-Prower factor, ke enzyme ea coagulation cascade.Factor X e sebelisoa, ka hydrolysis, ho factor Xa ka bobeli factor IX.Factor Xa is the activated form of the coagulation factorthrombokinase.Inhibiting Factor Xa e ka fana ka mokhoa o mong oa anticoagulation.Li-inhibitors tsa Direct Xa ke li-anticoagulants tse tsebahalang [2].
In vitro: Apixabanhas e bontšitse tekanyo e phahameng ea potency, selectivity, le katleho ho Factor Xa le Ki ea 0.08 nM le 0.17 nM bakeng sa Human Factor Xa le Rabbit Factor Xa, ka ho latellana [1].Apixaban e lelefatsa nako ea ho koala ha plasma e tloaelehileng ea motho ka li-concents (EC2x) tsa 3.6, 0.37, 7.4 le 0.4 μM, tse hlokehang ka ho latellana ho habeli nako ea prothrombin (PT), nako e fetotsoeng ea prothrombin (mPT), e entsoeng ka nako e itseng ea thromboplastin ( APTT) le HepTest.Ntle ho moo, Apixaban e bontšitse matla a phahameng ka ho fetisisa ho plasma ea batho le ea mmutla, empa matla a fokolang a plasma ea likhoto le lintja litlhahlobong tsa PT le APTT [3].
In vivo: Apixaban e hlahisitse pharmacokinetics e ntle ka ho fetisisa e nang le tumello e tlaase haholo (Cl: 0.02 L kg-1h-1), le palo e tlaase ea kabo (Vdss: 0.2 L / kg) ho ntja.Ntle ho moo, Apixaban e boetse e bonts'a halofo ea bophelo bo itekanetseng le T1 / 2 ea lihora tsa 5.8 le bioavailability e ntle ea molomo (F: 58%) [1].Ka har'a arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT) le mefuta ea meutlanyana ea carotid arterial thrombosis (ECAT), Apixaban e hlahisitse litlamorao tsa antithrombotic ka EC50 ea 270 nM, 110 nM le 70 nM ka mokhoa o itšetlehileng ka lethal dose [3. ].Apixaban e thibelitse haholo ts'ebetso ea Xa ka IC50 ea 0.22 μM ho mmutla ex vivo[4].Ka lichimpanzi, Apixaban o ile a boela a bontša palo e nyenyane ea ho aba (Vdss: 0.17 L kg-1), tumello e tlaase ea tsamaiso (Cl: 0.018 L kg-1h-1), le bioavailability e ntle ea molomo (F: 59%) [5].
Litšupiso:
Pinto DJP, Orwat MJ, Koch S, et al.Ho sibolloa ha 1-(4-methoxyphenyl) -7-oxo-6-(4-(2-oxopiperidin-1-yl) phenyl) -4, 5, 6, 7-tetrahydro-1 H-pyrazolo [3, 4- c] pyridine-3-carboxamide (Apixaban, BMS-562247), e matla haholo, e khethang, e sebetsang hantle, le ea molomo ea bioavailable inhibitor ea mali a coagulation factor Xa[J].Journal of chemistry ea meriana, 2007, 50 (22): 5339-5356.
Sidhu P S. Direct Factor Xa Inhibitors e le Anticoagulants[J].
Wong PC, Crain EJ, Xin B, et al.Apixaban, oral, e tobileng le e khethehileng haholo ea Xa inhibitor: in vitro, antithrombotic le antihemostaticstudies[J].Journal of Thrombosis le Haemostasis, 2008, 6 (5): 820-829.
Zhang D, He K, Raghavan N, et al.Metabolism, pharmacokinetics le pharmacodynamics ea factor Xa inhibitor apixaban ka mebutlanyana[J].Journal of thrombosis le thrombolysis, 2010, 29 (1): 70-80.
He K, Luettgen JM, Zhang D, et al.Preclinical pharmacokinetics le pharmacodynamics ea apixaban, e matla le e khethang factor Xa inhibitor[J].Koranta ea Europe ea metabolism ea lithethefatsi le pharmacokinetics, 2011, 36 (3): 129-139.
Sebopeho sa lik'hemik'hale
![2018 GMP-2](http://www.cz-pharma.com/uploads/beaa7119.jpg)
![原料药GMP证书201811(captopril ,thalidomide etc)](http://www.cz-pharma.com/uploads/15b802ef.jpg)
![GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co](http://www.cz-pharma.com/uploads/40ac545a.jpg)
![FDA-EIR-Letter-201901](http://www.cz-pharma.com/uploads/FDA-EIR-Letter-201901.jpg)
![Quality management1](http://www.cz-pharma.com/uploads/Quality-management1.png)
Tlhahiso18Merero ea Tlhahlobo ea Boleng e amohetsoeng4, le6merero e tlas'a tumello.
![Quality management2](http://www.cz-pharma.com/uploads/Quality-management2.png)
Sistimi e tsoetseng pele ea boleng ba machaba e thehile motheo o tiileng oa thekiso.
![Quality management3](http://www.cz-pharma.com/uploads/Quality-management3.png)
Tlhokomelo ea boleng e tsamaisana le potoloho eohle ea bophelo ba sehlahisoa ho netefatsa boleng le phello ea kalafo.
![Quality management4](http://www.cz-pharma.com/uploads/Quality-management4.png)
Sehlopha sa Litaba tsa Taolo ea Setsebi se tšehetsa litlhoko tsa boleng nakong ea kopo le ngoliso.
![cpf5](http://www.cz-pharma.com/uploads/cpf5.png)
![cpf6](http://www.cz-pharma.com/uploads/cpf6.png)
Korea Countec Bottled Packaging Line
![cpf7](http://www.cz-pharma.com/uploads/cpf7.png)
![cpf8](http://www.cz-pharma.com/uploads/cpf8.png)
Taiwan CVC Bottled Packaging Line
![cpf9](http://www.cz-pharma.com/uploads/cpf9.png)
![cpf10](http://www.cz-pharma.com/uploads/cpf10.png)
Italy CAM Board Packaging Line
![cpf11](http://www.cz-pharma.com/uploads/cpf11.png)
Mochini oa Sejeremane oa Fette Compacting
![cpf12](http://www.cz-pharma.com/uploads/cpf12.png)
Japan Viswill Tablet Detector
![cpf14-1](http://www.cz-pharma.com/uploads/cpf14-1.png)
Kamore ea ho laola ea DCS
![International cooperation](http://www.cz-pharma.com/uploads/International-cooperation.jpg)
![Domestic cooperation](http://www.cz-pharma.com/uploads/Domestic-cooperation.jpg)